CN Patent

CN114144192A — 包含ω-3脂肪酸盐和来自乳香属物种的胶树脂提取物的制剂

Assigned to Evonik Operations GmbH · Expires 2022-03-04 · 4y expired

What this patent protects

本发明涉及包含来自乳香属物种的胶树脂的至少一种提取物和选自二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)的至少一种ω‑3脂肪酸盐的制剂。令人惊奇地，这些来自乳香属物种的胶树脂提取物和多不饱和脂肪酸盐的组合以协同作用方式在特异性促分解介体(SPM)的生物合成中产生了显著和预料不到的增加，从而为炎性病症的消退提供了有益性。

USPTO Abstract

本发明涉及包含来自乳香属物种的胶树脂的至少一种提取物和选自二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)的至少一种ω‑3脂肪酸盐的制剂。令人惊奇地，这些来自乳香属物种的胶树脂提取物和多不饱和脂肪酸盐的组合以协同作用方式在特异性促分解介体(SPM)的生物合成中产生了显著和预料不到的增加，从而为炎性病症的消退提供了有益性。

Drugs covered by this patent

Patent Metadata

Patent number
CN114144192A
Jurisdiction
CN
Classification
—
Expires
2022-03-04
Drug substance claim
No
Drug product claim
No
Assignee
Evonik Operations GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.